Pomalong 4mg Pomalidomide Price USA | Ernest Oncology Indian Exporter

Pomalong 4mg Capsule: High-Potency Pomalidomide for Advanced Myeloma Management

Are you looking for a trusted Pomalong 4 mg capsule exporter from India? Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a leading global supplier and bulk distributor of advanced hematological treatments. We provide a high-authority, regulatory-compliant supply chain serving the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, ensuring that critical oncology medications reach healthcare providers with pharmaceutical-grade integrity and global logistics expertise.

Detailed Product Overview: What is Pomalong 4mg?

Pomalong 4 mg is an oral targeted therapy containing the active pharmaceutical ingredient Pomalidomide. It is a potent Immunomodulatory Imide (IMiD), specifically designed to address cases where previous lines of treatment have become ineffective. Pomalong is a third-generation IMiD, offering enhanced efficacy in inhibiting tumor growth and modulating the immune system compared to earlier generation treatments.

The 4mg strength represents the standard therapeutic dose for aggressive intervention in relapsed conditions, often administered in specific cycles to balance potency with patient safety.

Primary Therapeutic Indications: 

Pomalong 4 mg is clinically indicated for the management of:

1. Relapsed and Refractory Multiple Myeloma (RRMM): For adult patients who have received at least two prior therapies, including Lenalidomide and a proteasome inhibitor, and have demonstrated disease progression.

2. Kaposi Sarcoma (KS): Specifically for patients with AIDS-related KS who have failed highly active antiretroviral therapy (HAART) or in patients who are HIV-negative.

Mechanism of Action: How Pomalong 4 mg Works: 

Pomalong 4mg employs a sophisticated multi-pathway approach to combat malignant cells:

• Targeted Degradation: It binds to cereblon (part of the E3 ubiquitin ligase complex), leading to the selective degradation of Ikaros and Aiolos transcription factors. This results in the direct death of myeloma cells.

• Anti-Angiogenesis: It blocks the development of new blood vessels that supply tumors with oxygen and nutrients, effectively inhibiting tumor expansion.

• Immune System Modulation: It enhances the activity of T-cells and Natural Killer (NK) cells, empowering the body’s natural defenses to identify and eliminate "hidden" cancer cells.

• Cytokine Regulation: It inhibits the production of pro-inflammatory cytokines (such as TNF-α and IL-6) that otherwise support tumor survival in the bone marrow microenvironment.

Administration and Safety Guidelines: 

• Usage: Taken orally, once daily, usually in cycles (e.g., 21 days on, 7 days off in a 28-day cycle).

• Instruction: Capsules must be swallowed whole at the same time each day. Do not break, chew, or open them.

• Critical Safety Warning: Embryo-Fetal Toxicity. Pomalong can cause severe, life-threatening birth defects. Global distribution is strictly governed by REMS (Risk Evaluation and Mitigation Strategy) protocols.

• Clinical Monitoring: Regular blood tests (CBC) are required to monitor for neutropenia (low white blood cells) and thrombocytopenia (low platelets).

Why Source Pomalong 4 mg from Ernest Oncology?

• Direct Exporter from India: We provide direct access to GMP-certified manufacturing, ensuring 100% product authenticity and competitive bulk pricing.

• Specialized Global Logistics: Expertise in cross-border pharmaceutical trade for the UK, London, USA, Abu Dhabi, Australia, and South Africa.

• Bulk Inventory Support: Reliable availability of all strengths to prevent patient treatment gaps and support large-scale hospital procurement.

• Documentation Excellence: We provide all necessary COAs, export permits, and shipping documentation for smooth customs clearance.